WO2024261647 - IMPROVED SEED VIRUSES

National phase entry is expected:
Publication Number WO/2024/261647
Publication Date 26.12.2024
International Application No. PCT/IB2024/055963
International Filing Date 19.06.2024
Title **
[English] IMPROVED SEED VIRUSES
[French] VIRUS DE SEMENCE AMÉLIORÉS
Applicants **
SEQIRUS INC. 475 Green Oaks Parkway Holly Springs, North Carolina 27540, US
Inventors
EKBERG, Gregory c/ Seqirus Inc. 475 Green Oaks Parkway Holly Springs, North Carolina 27540, US
MCGEE, Charles c/ Seqirus Inc. 475 Green Oaks Parkway Holly Springs, North Carolina 27540, US
ERNST, Terika c/ Seqirus Inc. 475 Green Oaks Parkway Holly Springs, North Carolina 27540, US
GULLY, Christopher c/ Seqirus Inc. 475 Green Oaks Parkway Holly Springs, North Carolina 27540, US
Priority Data
63/508,946   19.06.2023   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
*
International Searching Authority
*
*
Applicant's Legal Status
*
*
*
*
*
Entry into National Phase under
*
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing2565
EPO Filing, Examination17246
Japan Filing532
South Korea Filing575
USA Filing, Examination13455
MasterCard Visa

Total: 34373

Abstract[English] The present disclosure relates to the field of influenza viruses. More particularly, this disclosure relates to donor or seed influenza viruses for use in preparing reassortant influenza viruses for vaccine production.[French] La présente divulgation se rapporte au domaine des virus de la grippe. La présente divulgation concerne plus particulièrement les virus grippaux donneurs ou de semence destinés à être utilisés dans la préparation de virus grippaux réassortis pour la production de vaccins.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙